Acasti Pharma Ownership
Who are the major shareholders and have insiders been buying or selling?
Recent Insider Transactions
Date | Value | Name | Entity | Role | Shares | Max Price |
---|---|---|---|---|---|---|
25 Sep 23 | BuyUS$1,249,934 | Vimal Kavuru | Individual | 676,371 | US$1.85 | |
25 Sep 23 | BuyUS$1,250,001 | Vimal Kavuru | Individual | 676,371 | US$1.85 | |
31 Aug 23 | BuyUS$781 | Donald Olds | Individual | 381 | US$2.05 |
Insider Trading Volume
Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.
Ownership Breakdown
Owner Type | Number of Shares | Ownership Percentage |
---|---|---|
Private Companies | 124,344 | 1.32% |
VC/PE Firms | 567,812 | 6.04% |
Institutions | 772,685 | 8.22% |
Individual Insiders | 2,836,715 | 30.2% |
General Public | 5,097,848 | 54.2% |
Dilution of Shares: Shareholders have been diluted in the past year, with total shares outstanding growing by 26.4%.
Top Shareholders
Ownership | Name | Shares | Current Value | Change % | Portfolio % | |
---|---|---|---|---|---|---|
1,614,399 | US$4.7m | 35.9% | no data | |||
781,592 | US$2.3m | 0% | no data | |||
567,812 | US$1.7m | 14.2% | 0.77% | |||
494,698 | US$1.4m | 0% | no data | |||
370,354 | US$1.1m | 0% | no data | |||
217,381 | US$634.8k | 530% | 0.2% | |||
124,344 | US$363.1k | 0% | no data | |||
37,895 | US$110.7k | 0% | no data | |||
36,650 | US$107.0k | 0% | no data | |||
21,357 | US$62.4k | 0% | no data | |||
12,000 | US$35.0k | -61.3% | no data | |||
11,118 | US$32.5k | -0.01% | no data | |||
3,112 | US$9.1k | 1.04% | no data | |||
2,901 | US$8.5k | 0% | no data | |||
1,947 | US$5.7k | -65.2% | no data | |||
1,882 | US$5.5k | 0% | no data | |||
1,500 | US$4.4k | 11,400% | no data | |||
584 | US$1.7k | 0% | no data | |||
28 | US$82.3 | 0% | no data | |||
2 | US$5.5 | 0% | no data |